Danaher Corp. closed 35.83% below its 52-week high of $281.70, which the company reached on August 1st.

Andvari Associates, an investment management firm, released its first-quarter 2025 investor letter. A copy of the letter can ...

Fintel reports that on April 10, 2025, Barclays upgraded their outlook for Danaher (NYSE:DHR) from Equal-Weight to Overweight. Analyst Price Forecast Suggests 40.08% Upside As of April 2, 2025, the ...

Barclays upgraded Danaher (DHR) to Overweight from Equal Weight with a price target of $205, down from $240. The firm cites its defensive ...

Barclays analyst Luke Sergott upgraded Danaher (DHR – Research Report) to a Buy today and set a price target of $205.00. The company’s shares ...

Rhenman & Partners Asset Management AB slashed its Danaher stake by 23.2% in Q4, unloading over 19,000 shares like a hot ...

The Oxford-based specialist in DNA and RNA sequencing technologies said it is teaming up with Sunnyvale, California-based Cepheid, a molecular diagnostics subsidiary of Washington DC-based life ...

Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases OXFORD, United Kingdom and SUNNYVALE ...

First Western Trust Bank trimmed 6.6% off its Danaher stake in Q4, selling 1,649 shares for a tidy $5.38 million holding.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

We recently published a list of 15 Stocks with Buy Ratings that Hedge Funds Love. In this article, we are going to take a ...

Hear from executives representing Coca-Cola Bottlers'​ Sales and Services, Finexio and Danaher Corporation at Procurement & ...